Information updates

New ASCIA food allergen challenge resources

ASCIA is intending to re-apply for a Medicare Benefits Schedule (MBS) item number for food allergen challenges in 2022. In preparation for this application, a new ASCIA Position Paper has been developed, following review by the ASCIA Paediatric committee, as well as a new Consent Form and Reference List. These resources are now available open access on the ASCIA website:

The new resources complement the ASCIA food allergen challenges FAQ for patients and carers, which is also available on the ASCIA website:

We note that in the Federal Budget announcement on Tuesday 29 March 2022, it was stated that the Australian Government’s investment would include support to improve access to allergy diagnostics and to gather evidence to support MBS items for food and drug challenge testing. Our aim is for the new resources listed above to assist in this process.

To read more about the Federal Budget announcement go to


This news item was issued on 4 April 2022 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand.  

Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia